Advaxis, Inc. Announces Three Abstracts Accepted for Presentation at Society for Immunotherapy of Cancer Annual Meeting

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Advaxis, Inc. (OTCQB:ADXS) (“Advaxis” or the “Company”), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that three abstracts describing research with Advaxis Lm-LLO immunotherapies have been selected for poster presentation at the Society for Immunotherapy of Cancer (SITC) 28th Annual Meeting, November 8-10, 2013 at the Gaylord National Hotel & Convention Center in National Harbor, MD.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC